Today, the American farmer and consumer is looking for nontoxic products to control pests. Biological control and related technologies have the potential to provide these nontoxic solutions for the control of plant pests and to increase plant growth and yield. Among the direct effects of biocontrol agents are: (a) disease control through induced resistance, (b) increased growth of roots and shoots (seed treatments may give season-long effects), (c) increased drought tolerance, (d) increased leaf greenness that probably results in greater photosynthetic rates, and (e) increased yields of a variety of crops. Similarly, rhizobacteria in the genera Pseudomonas and Bacillus have abilities to control plant diseases through multiple mechanisms, including antibiotic production and induced resistance. However, rhizobia (bacteria in the genera Bradyrhizobium, Rhizobium and Sinorhizobium) nodulate legumes and fix nitrogen, via complex plant-microbe interactions. OBJECTIVES: The goal of this project is to develop new and improved strains of biocontrol agents and delivery systems to meet the increased demand of the consumer for nontoxic solutions to pest problems by December 31, 2008. The objectives are: 1. To improve the existing formulation process to provide higher and more reproducible levels of viable bacteria and greater shelf life. 2. To develop strains of Trichoderma for seed treatment on wheat and other crops that provide significantly better performance than T. harzianum strain T22. 3. To develop methods for at least partial control of powdery mildew on foliage of greenhouse crops by seed or soil treatments that induce systemic resistance in plants. APPROACH: The grant will focus on three areas for highly successful biocontrol systems. 1. Elite microbial strains selected for high levels of efficacy. Strains of Trichoderma, Bacillus, and Bradyrhizobia are in hand and will be evaluated individually and in combinations to determine the most effective use. 2.Highly efficient microbial production systems. Microbial products must be produced efficiently to high quality standards. Depending upon the organism being produced, either liquid or semi-solid fermentation may be more cost-effective and produce the higher quality product. These systems are proprietary and will not be described here because of confidentiality issues. 3. Formulation processes.Once the microbial agents are produced, they must be formulated into highly effective products. ABM, together with Dr. Harman at Cornell University, has developed and filed a patent for a universal method of formulating microbial inoculants. The system can be used with any microbe that produces cells or spores that can be processed as a suspension in water. The concentrated cells or spores are mixed with dry powders; cellulose and cyclodextrins are the preferred materials